Research Programmes / Core Facilities

Mouse Mutant Core Facility
Marta Vilaseca
Annie Rodolosse
Nick Berrow
Camille Stephan-otto Attolini
Histology Service

Research Programmes

  • Cell and Developmental Biology
    More about Cell and Developmental Biology
  • Structural and Computational Biology
    More about Structural and Computational Biology
  • Molecular Medicine
    More about Molecular Medicine
  • Chemistry and Molecular Pharmacology
    More about Chemistry and Molecular Pharmacology
  • Oncology
    More about Oncology

Core Facilities & Services

Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.

Interdisciplinary initiatives

IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine

Selected IRB Barcelona publications

Kessler R, Tisserand J, Font-Burgada J, Reina O, Coch L, Attolini CS, Garcia-Bassets I and Azorín F.
Nat Commun, 6 7049 (2015)
Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello DV, Byrom D, Cortina C, Morral C, Barceló C, Tosi S, Riera A, Attolini CS, Rossell D, Sancho E and Batlle E.
Nat Genet, 47 (4), 320-329 (2015)
Lecland N and Lüders J.
Nat Cell Biol, 16 (8), 770-8 (2014)
Fenwick RB, Orellana L, Esteban-Martín S, Orozco M and Salvatella X.
Nat Commun, 5 4070 (2014)
Urosevic J, Garcia-Albéniz X, Planet E, Real S, Céspedes MV, Guiu M, Fernandez E, Bellmunt A, Gawrzak S, Pavlovic M, Mangues R, Dolado I, Barriga FM, Nadal C, Kemeny N, Batlle E, Nebreda AR and Gomis RR.
Nat Cell Biol, 16 (7), 685-94 (2014)
<p>cell 2014</p>
Boer DR, Freire-Rios A, van den Berg WA, Saaki T, Manfield IW, Kepinski S, López-Vidrieo I, Franco-Zorrilla JM, de Vries SC, Solano R, Weijers D and Coll M.
Cell, 156 (3), 577-89 (2014)
Bava FA, Eliscovich C, Ferreira PG, Miñana B, Ben-Dov C, Guigó R, Valcárcel J and Méndez R.
Nature, 495 (7439), 121-5 (2013)
<p>Cancer Cell</p>
Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massagué J, Sancho E and Batlle E.
Cancer Cell, 22 (5), 571-84 (2012)
<p>Nature 2012</p>
Jung P, Sato T, Merlos-Suárez A, Barriga FM, Iglesias M, Rossell D, Auer H, Gallardo M, Blasco MA, Sancho E, Clevers H and Batlle E.
Nat Med, 17 (10), 1225-7 (2011)

News

21 May 2015

Observing the movement of cells inside an organism, following the development of an embryo in vivo over two days, or seeing how synapses form between neurons are the challenges faced by  m

11 May 2015

ELIXIR has been awarded €19 million from the EU to accelerate the implementation of Europe’s life-science data infrastructure over the next four years.

30 Apr 2015

ECMED will be developed through a public-private consortium led by the University College London (UK), and will engage other 10 organizations from several European countries.

28 Apr 2015

Until today, the proteins known as ubiquitin receptors have been associated mainly with protein degradation, a basic cell cleaning process.

Upcoming events

09 Jun

Technology transfer: turning academic results into business opportunities by Marc Ramis Castelltort, CEO at Tech & Business Innovation (TBI)

 

11 Jun

Speakers:

  • Raül Insa, CEO, SOM Biotech
  • Rosina Malagrida, Head of Public Engagement on Health Research, Institut de Recerca de la Sida IrsiCaixa
  • Goretti Mallorquí, Scientific Officer, Research and Academic Administration Department, IRB Barcelona
  • Dominique Monferrer, Regulatory Affairs Manager at Asphalion
  • Marusela Oliveras, Junior Business Development Manager, Erasmus MC
  • Jordi Quintana, Head of Business Development, Director of Drug Discovery Platform, PCB
  • Markus Wilhelms, PhD, CEO and Co-Founder of usMIMA
15 Jun

Barcelona BioMed Conference

Organisers: Cayetano González, IRB Barcelona (Barcelona, Spain) and Marco Milán, IRB Barcelona (Barcelona, Spain)

 

18 Jun

Speaker: Hector Peinado, PhD - Microenvironment & Metastasis Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid